Legal & General Group
IRON icon

Legal & General Group’s Disc Medicine IRON Stock Holding History

Legal & General Group’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
18,458
-919
-5% -$63.1K ﹤0.01% 2097
2026
Q1 		$1.24M Sell
19,377
-4,276
-18% -$297K ﹤0.01% 2074
2025
Q4 		$1.88M Sell
23,653
-1,494
-6% -$126K ﹤0.01% 1993
2025
Q3 		$1.66M Buy
25,147
+1,050
+4% +$62.5K ﹤0.01% 2056
2025
Q2 		$1.28M Buy
24,097
+3,682
+18% +$173K ﹤0.01% 2165
2025
Q1 		$1.01M Buy
20,415
+2,727
+15% +$152K ﹤0.01% 2186
2024
Q4 		$1.12M Buy
17,688
+3,051
+21% +$176K ﹤0.01% 2200
2024
Q3 		$719K Buy
14,637
+655
+5% +$30.8K ﹤0.01% 2346
2024
Q2 		$630K Buy
13,982
+5,214
+59% +$177K ﹤0.01% 2342
2024
Q1 		$546K Sell
8,768
-14
-0.2% -$908 ﹤0.01% 2390
2023
Q4 		$507K Buy
8,782
+7
+0.1% +$358 ﹤0.01% 2442
2023
Q3 		$412K Buy
8,775
+7,850
+849% +$393K ﹤0.01% 2507
2023
Q2 		$41.1K Buy
+925
New +$32.8K ﹤0.01% 2897
2022
Q2 		– Sell
-81
Closed -$3K – 3592
2022
Q1 		$3K Hold
81
– – ﹤0.01% 3537
2021
Q4 		$7K Hold
81
– – ﹤0.01% 3517
2021
Q3 		$10K Buy
81
+23
+40% +$3.14K ﹤0.01% 3445
2021
Q2 		$11K Buy
+58
New +$19.1K ﹤0.01% 3411

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group's IRON Position: Q2 2026 in Review

Legal & General Group reduced its Disc Medicine (IRON) stake by 4.7% in Q2 2026, selling an estimated $63.1K and leaving 18,458 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

Legal & General Group first reported a position in IRON in Q2 2021 and has held it in 17 quarters since. The position peaked at $1.88M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Legal & General Group held 18,458 shares of Disc Medicine worth $1.35M as of Q2 2026.
  • Legal & General Group sold 919 Disc Medicine shares in Q2 2026, an estimated $63.1K.
  • Disc Medicine made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2097 holding.
  • Legal & General Group first reported a position in Disc Medicine in Q2 2021 and has held it in 17 quarters since.
  • Legal & General Group's Disc Medicine position peaked at $1.88M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.